Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109799601000001119 | Nicotinic acid 1g modified-release tablets (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109799701000001112 | Nicotinic acid 1g modified-release tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nicotinic acid 1g modified-release tablets 56 tablet | Has VMP | False | Nicotinic acid 1g modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Niaspan 1g modified-release tablets (Sigma Pharmaceuticals Plc) | Is a | False | Nicotinic acid 1g modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Niaspan 1g modified-release tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Nicotinic acid 1g modified-release tablets | Inferred relationship | Existential restriction modifier | |
| Niaspan 1g modified-release tablets (Merck Pharmaceuticals) | Is a | False | Nicotinic acid 1g modified-release tablets | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets